Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Bosch

Showing results (491-500 of 503) with videos related to

Pageof 51
Sort By:
International Journal of Surgical Pathology|November 13, 2024
Human Papillomavirus (HPV) Genotypes in Mixed Squamous Cell Carcinoma of the Penis: A Study of 101 TumorsMaría José Fernández-Nestosa, Diego F Sanchez, Sofia Cañete-Portillo, et al.
International Journal of Cancer|March 20, 2017
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinomaDana Holzinger, Gunnar Wichmann, Lorena Baboci, et al.
British Journal of Cancer|March 5, 2002
Prevalence and determinants of human papillomavirus genital infection in menS Franceschi, X Castellsagué, L Dal Maso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2009
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24S Majewski, F X Bosch, J Dillner, et al.
Sexually Transmitted Diseases|November 1, 1996
Risk factors for HPV DNA detection in middle-aged womenN Muñoz, I Kato, F X Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancerP Viladiu, F X Bosch, X Castellsagué, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
International Journal of Cancer|June 15, 2019
New perspectives on screening and early detection of endometrial cancerLaura Costas, Jon Frias-Gomez, Magdalena Guardiola, et al.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
Pageof 51

Showing results (491-500 of 503) with videos related to

Sort By:
Pageof 51
International Journal of Surgical Pathology|November 13, 2024
Human Papillomavirus (HPV) Genotypes in Mixed Squamous Cell Carcinoma of the Penis: A Study of 101 TumorsMaría José Fernández-Nestosa, Diego F Sanchez, Sofia Cañete-Portillo, et al.
International Journal of Cancer|March 20, 2017
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinomaDana Holzinger, Gunnar Wichmann, Lorena Baboci, et al.
British Journal of Cancer|March 5, 2002
Prevalence and determinants of human papillomavirus genital infection in menS Franceschi, X Castellsagué, L Dal Maso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2009
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24S Majewski, F X Bosch, J Dillner, et al.
Sexually Transmitted Diseases|November 1, 1996
Risk factors for HPV DNA detection in middle-aged womenN Muñoz, I Kato, F X Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancerP Viladiu, F X Bosch, X Castellsagué, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
International Journal of Cancer|June 15, 2019
New perspectives on screening and early detection of endometrial cancerLaura Costas, Jon Frias-Gomez, Magdalena Guardiola, et al.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
Pageof 51